As of 4:01pm ET
| +0.07 / +0.07%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 135.00, with a high estimate of 135.00 and a low estimate of 135.00. The median estimate represents a +28.67% increase from the last price of 104.92.
The current consensus among 2 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.